41 / 72 fast facts on irhythm privately held company number of employees: approximately 300 ? the company continues to expand its sales force to enable growth. located in san francisco, ca raised nearly $100 million in equity from private investors. novo led the company?s series e round. fig. 2 the zio ® xt patch report is a comprehensive easy to read summary of findings based on an analysis performed by ecg technicians. this data to refine and enhance its algorithms, therefore providing the highest quality results, unmatched by any other cardiac monitoring service. with the financial support of a strong investor base including novo a/s, irhythm has experienced 70 per cent growth in its revenues in the last year, with more than 400,000 patches sold since approval. zio ® xt patch report for patch report, patient #10 patient id 123-456 date of birth 01/01/35 (78 yrs) gender female prescribing clinician dr. e. physician managing location incc lincolnshire primary indication atrial fibrillation enrollment period 04/04/13, 12:18pm to 04/18/13, 10:55am 13 days 23 hours analysis time 13 days 21 hours (after artifact removed) heart rate maximum hr 209
